pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 30·1 min read
save

Can AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and more

Welcome back to Endpoints Weekly! We’ve got a team of reporters on the ground in Chicago this weekend for ASCO, including my fellow Weekly co-author Max Gelman. If you haven’t already, check out Max’s story ...

May 30, 2026·read at Endpoints ↗

May 30, 2026 06:00 AM EDT Weekly Can AI do sci­en­tif­ic re­search?; The 'mag­ic bul­let' search has fad­ed in im­munother­a­py; and more Nicole DeFeudis Senior Reporter Max Gelman Senior Editor Wel­come back to End­points Week­ly! We’ve got a team of re­porters on the ground in Chica­go this week­end for AS­CO, in­clud­ing my fel­low Week­ly co-au­thor … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
90 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 30m agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 1h agoHealth tech investors are looking at bigger betsEndpoints
  • 4h agoSummit, Akeso say ivonescimab clears OS bar in Phase 3 lung cancer trialEndpoints
  • 5h agoSuperluminal secures $60M for Phase 1 of genetic obesity drugEndpoints
  • 5h agoGSK to license Hutchmed’s KRAS-EGFR cancer drug for $110M upfrontEndpoints